Hansa Rostock slapped with reduced seating after vandalising Aachen's Tivoli Stadion
The bosses at 3.Liga side Hansa Rostock have taken action following last Sunday’s destruction caused by their own fans in ...
Hosted on MSN1mon
Hansa Biopharma sees 2025 growth through expanded IDEFIRIX adoption and new market reimbursements
The company plans to advance its pivotal Phase 3 trial for the U.S. market ... this through restructuring and cost controls. Hansa Biopharma delivered strong full-year sales growth for 2024 ...
GlobalData on MSN10d
Hansa Biopharma enrols all subjects in imlifidase trial for kidney transplants
Swedish biotechnology company Hansa Biopharma has finished enrolling subjects in a Phase III trial in Europe evaluating survival rates among kidney transplant subjects who have undergone ...
Earnings call transcript: Hansa Biopharma Q4 2024 misses EPS, stock drops
Hansa Biopharma's Q4 2024 EPS was -4.08, missing forecasts by over 100%. Revenue for the quarter was 32.3 million SEK, below expectations. The company's stock fell by 19.57% in pre-market trading.